GSK3B and cancer: Cellular and tissue analyses consistently demonstrate the abundant expression of GSK-3β in these cancers, underscoring its potential as a key target in cancer therapy (R, 2010), This shows that GSK-3β is significantly related to the occurrence and development of these tumors.